{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:46:56Z","timestamp":1788292016935,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00210-023-02529-y","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T19:01:40Z","timestamp":1685041300000},"page":"2813-2830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic potential of flavonoids in the management of obesity-induced Alzheimer\u2019s disease: an overview of preclinical and clinical studies"],"prefix":"10.1007","volume":"396","author":[{"given":"Sakshi M.","family":"Kothawade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpal Singh","family":"Buttar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep Singh","family":"Tuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"2529_CR1","doi-asserted-by":"publisher","unstructured":"Abbas H, el Sayed NS, Youssef NAHA, Gaafar PME, Mousa MR, Fayez AM, Elsheikh MA (2022). Novel luteolin\u2010loaded chitosan decorated nanoparticles for brain\u2010targeting delivery in a sporadic Alzheimer\u2019s disease mouse model: focus on antioxidant, anti\u2010inflammatory, and amyloidogenic pathways. Pharmaceutics 14. https:\/\/doi.org\/10.3390\/pharmaceutics14051003","DOI":"10.3390\/pharmaceutics14051003"},{"key":"2529_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1021\/cn400024q","volume":"4","author":"AH Abuznait","year":"2013","unstructured":"Abuznait AH, Qosa H, Busnena BA, el Sayed KA, Kaddoumi A (2013) Olive-oil-derived oleocanthal enhances \u03b2-amyloid clearance as a potential neuroprotective mechanism against Alzheimer\u2019s disease: in vitro and in vivo studies. ACS Chem Neurosci 4:973\u2013982. https:\/\/doi.org\/10.1021\/cn400024q","journal-title":"ACS Chem Neurosci"},{"key":"2529_CR3","doi-asserted-by":"publisher","unstructured":"Ahmed Z, Pal A, Bagwe-Parab S, Kaur G, Buttar HS, Tuli HS (2020) Role of flavonoids in obesity induced cardiovascular dysfunction. In: Tappia PS, Bhullar SK, Dhalla NS (eds) Biochemistry of cardiovascular dysfunction in obesity. Advances in Biochemistry in Health and Disease, vol 20. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-47336-5_16","DOI":"10.1007\/978-3-030-47336-5_16"},{"key":"2529_CR4","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.2174\/0929867325666180209132125","volume":"25","author":"C Airoldi","year":"2018","unstructured":"Airoldi C, la Ferla B, D`Orazio, G., Ciaramelli, C., Palmioli, A., (2018) Flavonoids in the treatment of Alzheimer\u2019s and other neurodegenerative diseases. Curr Med Chem 25:3228\u20133246. https:\/\/doi.org\/10.2174\/0929867325666180209132125","journal-title":"Curr Med Chem"},{"key":"2529_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.06.010","author":"M Bakhtiari","year":"2017","unstructured":"Bakhtiari M, Panahi Y, Ameli J, Darvishi B (2017) Protective effects of flavonoids against Alzheimer\u2019s disease-related neural dysfunctions. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2017.06.010","journal-title":"Biomed Pharmacother"},{"key":"2529_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020280","author":"P Bellavite","year":"2023","unstructured":"Bellavite P (2023) Neuroprotective potentials of flavonoids: experimental studies and mechanisms of action. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12020280","journal-title":"Antioxidants"},{"key":"2529_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2174\/1570159x18666200122122512","volume":"18","author":"H Birla","year":"2020","unstructured":"Birla H, Minocha T, Kumar G, Misra A, Singh SK (2020) Role of oxidative stress and metal toxicity in the progression of Alzheimer\u2019s disease. Curr Neuropharmacol 18:552\u2013562. https:\/\/doi.org\/10.2174\/1570159x18666200122122512","journal-title":"Curr Neuropharmacol"},{"key":"2529_CR8","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.230303","author":"M Chen","year":"2018","unstructured":"Chen M, Du ZY, Zheng X, Li DL, Zhou RP, Zhang K (2018) Use of curcumin in diagnosis, prevention, and treatment of Alzheimer\u2019s disease. Neural Regen Res. https:\/\/doi.org\/10.4103\/1673-5374.230303","journal-title":"Neural Regen Res"},{"key":"2529_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1703","author":"JW Daily","year":"2021","unstructured":"Daily JW, Kang S, Park S (2021) Protection against Alzheimer\u2019s disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis. BioFactors. https:\/\/doi.org\/10.1002\/biof.1703","journal-title":"BioFactors"},{"key":"2529_CR10","doi-asserted-by":"publisher","unstructured":"de Andrade Teles RB, Diniz TC, Costa Pinto TC, de Oliveira RG, e Silva MG, de Lavor \u00c9M, Fernandes AWC, de Oliveira AP, de Almeida Ribeiro FPR, da Silva AAM, Cavalcante TCF, Quintans LJ, da Silva Almeida JRG, (2018). Flavonoids as therapeutic agents in Alzheimer\u2019s and Parkinson\u2019s diseases: a systematic review of preclinical evidences. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2018\/7043213","DOI":"10.1155\/2018\/7043213"},{"key":"2529_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101095","author":"S Ebrahimpour","year":"2020","unstructured":"Ebrahimpour S, Zakeri M, Esmaeili A (2020) Crosstalk between obesity, diabetes, and alzheimer\u2019s disease: introducing quercetin as an effective triple herbal medicine. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2020.101095","journal-title":"Ageing Res Rev"},{"key":"2529_CR12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17591","author":"M Esang","year":"2021","unstructured":"Esang M, Gupta M (2021) Aducanumab as a novel treatment for Alzheimer\u2019s Disease: a decade of hope, controversies, and the future. Cureus. https:\/\/doi.org\/10.7759\/cureus.17591","journal-title":"Cureus"},{"key":"2529_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054354","author":"A Ezkurdia","year":"2023","unstructured":"Ezkurdia A, Ram\u00edrez MJ, Solas M (2023) Metabolic syndrome as a risk factor for Alzheimer\u2019s disease: a focus on insulin resistance. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24054354","journal-title":"Int J Mol Sci"},{"key":"2529_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095202","author":"JA Flores-Cordero","year":"2022","unstructured":"Flores-Cordero JA, P\u00e9rez-P\u00e9rez A, Jim\u00e9nez-Cortegana C, Alba G, Flores-Barrag\u00e1n A, S\u00e1nchez-Margalet V (2022) Obesity as a risk factor for dementia and Alzheimer\u2019s disease: the role of leptin. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23095202","journal-title":"Int J Mol Sci"},{"key":"2529_CR15","doi-asserted-by":"publisher","unstructured":"Gella A, Durany N (2009) Oxidative stress in Alzheimer disease. Cell Adh Migr 3:88\u201393. https:\/\/doi.org\/10.4161\/cam.3.1.7402","DOI":"10.4161\/cam.3.1.7402"},{"key":"2529_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuint.2015.07.026","volume":"89","author":"S Hagl","year":"2015","unstructured":"Hagl S, Kocher A, Schiborr C, Kolesova N, Frank J, Eckert GP (2015) Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice - impact on bioavailability. Neurochem Int 89:234\u2013242. https:\/\/doi.org\/10.1016\/j.neuint.2015.07.026","journal-title":"Neurochem Int"},{"key":"2529_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)70016-5","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, el Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"key":"2529_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/bpl-200098","volume":"6","author":"KL Hole","year":"2020","unstructured":"Hole KL, Williams RJ (2020) Flavonoids as an intervention for Alzheimer\u2019s disease: progress and hurdles towards defining a mechanism of action. Brain Plasticity 6:167\u2013192. https:\/\/doi.org\/10.3233\/bpl-200098","journal-title":"Brain Plasticity"},{"key":"2529_CR19","doi-asserted-by":"publisher","unstructured":"Kemper C, Behnam D, Brothers S, Wahlestedt C, Volmar C-H, Bennett D, Hayward M, (2022). Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL TM). AAPS Open 8. https:\/\/doi.org\/10.1186\/s41120-022-00058-1","DOI":"10.1186\/s41120-022-00058-1"},{"key":"2529_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4051207","author":"MS Khan","year":"2021","unstructured":"Khan MS, Ikram M, Park TJ, Kim MO (2021) Pathology, risk factors, and oxidative damage related to type 2 diabetes-mediated Alzheimer\u2019s disease and the rescuing effects of the potent antioxidant anthocyanin. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2021\/4051207","journal-title":"Oxid Med Cell Longev"},{"key":"2529_CR21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.biopha.2017.11.047","volume":"97","author":"kheradmand, E., Hajizadeh Moghaddam","year":"2018","unstructured":"kheradmand, E., Hajizadeh Moghaddam, A., Zare, M., (2018) Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer\u2019s disease. Biomed Pharmacother 97:1096\u20131101. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.047","journal-title":"Biomed Pharmacother"},{"key":"2529_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/162750","author":"S Kumar","year":"2013","unstructured":"Kumar S, Pandey AK (2013) Chemistry and biological activities of flavonoids: an overview. Sci World J. https:\/\/doi.org\/10.1155\/2013\/162750","journal-title":"Sci. World J."},{"key":"2529_CR23","doi-asserted-by":"crossref","unstructured":"Li F, Gong Q, Dong H, Shi J, (2012). Resveratrol, a neuroprotective supplement for Alzheimer\u2019s disease, Current Pharmaceutical Design","DOI":"10.2174\/138161212798919075"},{"key":"2529_CR24","doi-asserted-by":"publisher","unstructured":"Lloret A, Monllor P, Esteve D, Cervera-Ferri A, Lloret MA (20190. Obesity as a risk factor for Alzheimer\u2019s disease: implication of leptin and glutamate. Front Neurosci 13. https:\/\/doi.org\/10.3389\/fnins.2019.00508","DOI":"10.3389\/fnins.2019.00508"},{"key":"2529_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijpharm.2009.03.021","volume":"375","author":"X Lu","year":"2009","unstructured":"Lu X, Ji C, Xu H, Li X, Ding H, Ye M, Zhu Z, Ding D, Jiang X, Ding X, Guo X (2009) Resveratrol-loaded polymeric micelles protect cells from A\u03b2-induced oxidative stress. Int J Pharm 375:89\u201396. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.03.021","journal-title":"Int J Pharm"},{"key":"2529_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21091243","author":"G Mazzanti","year":"2016","unstructured":"Mazzanti G, di Giacomo S (2016) Curcumin and resveratrol in the management of cognitive disorders: What is the clinical evidence? Molecules. https:\/\/doi.org\/10.3390\/molecules21091243","journal-title":"Molecules"},{"key":"2529_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6038996","author":"T Minocha","year":"2022","unstructured":"Minocha T, Birla H, Obaid AA, Rai V, Sushma P, Shivamallu C, Moustafa M, Al-Shehri M, Al-Emam A, Tikhonova MA, Yadav SK, Poeggeler B, Singh D, Singh SK (2022) Flavonoids as promising neuroprotectants and their therapeutic potential against Alzheimer\u2019s disease. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2022\/6038996","journal-title":"Oxid Med Cell Longev"},{"key":"2529_CR28","doi-asserted-by":"publisher","unstructured":"Moreira PI (2010). Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Eur Neurol Rev 5, 17\u201321. https:\/\/doi.org\/10.17925\/ENR.2010.05.01.17","DOI":"10.17925\/ENR.2010.05.01.17"},{"key":"2529_CR29","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1089\/jmf.2014.0053","volume":"18","author":"PP Nahar","year":"2015","unstructured":"Nahar PP, Slitt AL, Seeram NP (2015) Anti-inflammatory effects of novel standardized solid lipid curcumin formulations. J Med Food 18:786\u2013792. https:\/\/doi.org\/10.1089\/jmf.2014.0053","journal-title":"J Med Food"},{"key":"2529_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-020-03031-0","author":"TT Nguyen","year":"2020","unstructured":"Nguyen TT, Ta QTH, Nguyen TTD, Le TT, Vo VG (2020) Role of insulin resistance in the Alzheimer\u2019s disease progression. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-020-03031-0","journal-title":"Neurochem Res"},{"key":"2529_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30084-4","author":"PD O\u2019Brien","year":"2017","unstructured":"O\u2019Brien PD, Hinder LM, Callaghan BC, Feldman EL (2017) Neurological consequences of obesity. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(17)30084-4","journal-title":"Lancet Neurol"},{"key":"2529_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.585887","author":"M Obradovic","year":"2021","unstructured":"Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T, Isenovic ER (2021) Leptin and obesity: role and clinical implication. Front Endocrinol (lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.585887","journal-title":"Front Endocrinol (lausanne)"},{"key":"2529_CR33","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2016.41","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci. https:\/\/doi.org\/10.1017\/jns.2016.41","journal-title":"J Nutr Sci"},{"key":"2529_CR34","doi-asserted-by":"crossref","unstructured":"Pegueroles J, Jim\u00e9nez A, Vilaplana E, Montal V, Carmona-Iragui M, Pan\u00e9 A, Alcolea D, Videla L, Casajoana A, Clarim\u00f3n J, Ortega E, Vidal J, Blesa R, Lle\u00f3 A, Fortea J (2018). Obesity and Alzheimer\u2019s disease, does the obesity paradox really exist? A magnetic resonance imaging study, Oncotarget","DOI":"10.18632\/oncotarget.26162"},{"key":"2529_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.876614","author":"I Piccialli","year":"2022","unstructured":"Piccialli I, Tedeschi V, Caputo L, D\u2019Errico S, Ciccone R, de Feo V, Secondo A, Pannaccione A (2022) Exploring the therapeutic potential of phytochemicals in Alzheimer\u2019s disease: focus on polyphenols and monoterpenes. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.876614","journal-title":"Front Pharmacol"},{"key":"2529_CR36","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00224","author":"P Prasanna","year":"2021","unstructured":"Prasanna P, Upadhyay A (2021) Flavonoid-based nanomedicines in Alzheimer\u2019s disease therapeutics: promises made, a long way to go. ACS Pharmacol Transl Sci. https:\/\/doi.org\/10.1021\/acsptsci.0c00224","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2529_CR37","doi-asserted-by":"publisher","unstructured":"Qusa MH, Siddique AB, Nazzal S, el Sayed KA (2019). Novel olive oil phenolic (\u2212)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities. Int J Pharm 569. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118596","DOI":"10.1016\/j.ijpharm.2019.118596"},{"key":"2529_CR38","doi-asserted-by":"publisher","first-page":"11849","DOI":"10.1021\/acsomega.0c01818","volume":"5","author":"B Salehi","year":"2020","unstructured":"Salehi B, Machin L, Monzote L, Sharifi-Rad J, Ezzat SM, Salem MA, Merghany RM, el Mahdy NM, Klll\u00e7 CS, Sytar O, Sharifi-Rad M, Sharopov F, Martins N, Martorell M, Cho WC (2020) Therapeutic potential of quercetin: new insights and perspectives for human health. ACS Omega 5:11849\u201311872. https:\/\/doi.org\/10.1021\/acsomega.0c01818","journal-title":"ACS Omega"},{"key":"2529_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119129","author":"E Se Thoe","year":"2021","unstructured":"Se Thoe E, Fauzi A, Tang YQ, Chamyuang S, Chia AYY (2021) A review on advances of treatment modalities for Alzheimer\u2019s disease. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2021.119129","journal-title":"Life Sci"},{"key":"2529_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.colsurfb.2016.08.052","volume":"148","author":"D Sun","year":"2016","unstructured":"Sun D, Li N, Zhang W, Zhao Z, Mou Z, Huang D, Liu J, Wang W (2016) Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer\u2019s disease. Colloids Surf B Biointerfaces 148:116\u2013129. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.08.052","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2529_CR41","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1517\/14712598.2011.619974","volume":"11","author":"CS Tam","year":"2011","unstructured":"Tam CS, Lecoultre V, Ravussin E (2011) Novel strategy for the use of leptin for obesity therapy. Expert Opin Biol Ther 11:1677\u20131685. https:\/\/doi.org\/10.1517\/14712598.2011.619974","journal-title":"Expert Opin Biol Ther"},{"key":"2529_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12291-015-0514-0","volume":"31","author":"S Tangvarasittichai","year":"2016","unstructured":"Tangvarasittichai S, Pongthaisong S, Tangvarasittichai O (2016) Tumor necrosis factor-\u0391, interleukin-6, C-reactive protein levels and insulin resistance associated with type 2 diabetes in abdominal obesity women. Indian J Clin Biochem 31:68\u201374. https:\/\/doi.org\/10.1007\/s12291-015-0514-0","journal-title":"Indian J Clin Biochem"},{"key":"2529_CR43","first-page":"21","volume":"9","author":"IG Telessy","year":"2017","unstructured":"Telessy IG, Buttar HS (2017a) Obesity related alterations in pharmacokinetics and pharmacodynamics of drugs: emerging clinical implications in obese patients -Part I. Adipobiology 9:21\u201330","journal-title":"Adipobiology"},{"key":"2529_CR44","first-page":"31","volume":"9","author":"IG Telessy","year":"2017","unstructured":"Telessy IG, Buttar HS (2017b) Obesity related alterations in pharmacokinetics and pharmacodynamics of drugs: emerging clinical implications in obese patients- Part 11. Adipobiology 9:31\u201340","journal-title":"Adipobiology"},{"key":"2529_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jff.2019.05.004","volume":"59","author":"R Varshney","year":"2019","unstructured":"Varshney R, Mishra R, Das N, Sircar D, Roy P (2019) A comparative analysis of various flavonoids in the regulation of obesity and diabetes: an in vitro and in vivo study. J Funct Foods 59:194\u2013205. https:\/\/doi.org\/10.1016\/j.jff.2019.05.004","journal-title":"J Funct Foods"},{"key":"2529_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.09.010","author":"RJ Williams","year":"2012","unstructured":"Williams RJ, Spencer JPE (2012) Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.09.010","journal-title":"Free Radic Biol Med"},{"key":"2529_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.01.001","author":"RJ Williams","year":"2004","unstructured":"Williams RJ, Spencer JPE, Rice-Evans C (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.01.001","journal-title":"Free Radic Biol Med"},{"key":"2529_CR48","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00394-019-02105-2","volume":"59","author":"Z Yari","year":"2020","unstructured":"Yari Z, Movahedian M, Imani H, Alavian SM, Hedayati M, Hekmatdoost A (2020) The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial. Eur J Nutr 59:2569\u20132577. https:\/\/doi.org\/10.1007\/s00394-019-02105-2","journal-title":"Eur J Nutr"},{"key":"2529_CR49","doi-asserted-by":"publisher","unstructured":"Yoshitomi R, Yamamoto M, Kumazoe M, Fujimura Y, Yonekura M, Shimamoto Y, Nakasone A, Kondo S, Hattori H, Haseda A, Nishihira J, Tachibana H (2021). The combined effect of green tea and \u03b1-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial. Sci Rep 11. https:\/\/doi.org\/10.1038\/s41598-021-98612-6","DOI":"10.1038\/s41598-021-98612-6"},{"key":"2529_CR50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1046\/j.1471-4159.2003.01652.x","volume":"85","author":"KA Youdim","year":"2003","unstructured":"Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C (2003) Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 85:180\u2013192. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01652.x","journal-title":"J Neurochem"},{"key":"2529_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020493","author":"XW Zhang","year":"2020","unstructured":"Zhang XW, Chen JY, Ouyang D, Lu JH (2020) Quercetin in animal models of Alzheimer\u2019s disease: a systematic review of preclinical studies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21020493","journal-title":"Int J Mol Sci"},{"key":"2529_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1459497","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Chen B, Shen J, Wan L, Zhu Y, Yi T, Xiao Z (2017) The beneficial effects of quercetin, curcumin, and resveratrol in obesity. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2017\/1459497","journal-title":"Oxid Med Cell Longev"},{"key":"2529_CR53","doi-asserted-by":"publisher","unstructured":"Zheng M, Chang B, Tian L, Shan C, Chen H, Gao Y, Huang G, Zhang M (2019). Relationship between inflammatory markers and mild cognitive impairment in Chinese patients with type 2 diabetes: a case-control study. BMC Endocr Disord 19. https:\/\/doi.org\/10.1186\/s12902-019-0402-3","DOI":"10.1186\/s12902-019-0402-3"},{"key":"2529_CR54","doi-asserted-by":"publisher","unstructured":"Zu G, Sun K, Li L, Zu X, Han T, Huang H (2021). Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus. Sci Rep 11. https:\/\/doi.org\/10.1038\/s41598-021-02248-5","DOI":"10.1038\/s41598-021-02248-5"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02529-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T06:12:32Z","timestamp":1697004752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02529-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2529"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02529-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"8 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}